Daré Bioscience to present sildenafil cream Phase 1 data at SMSNA

October 8, 2026 9:15 AM

Daré Bioscience, Inc. (NASDAQ: DARE) announced it will present Phase 1 clinical data for its proprietary Sildenafil Cream, 3.6% at ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found